Report overview
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that causes a continuous progressive degeneration of the macula. The condition is characterized by widespread atrophy of the outer retinal tissue, retinal pigment epithelium, and choriocapillaris. It typically starts in the perifoveal region and develops to the fovea over time and causing central scotomas and permanent vision loss. Various drugs and treatments are under evaluation.
This report contains market size and forecasts of Geographic Atrophy Treatment in Global, including the following market information:
Global Geographic Atrophy Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Geographic Atrophy Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Late-stage (Phase III) Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Geographic Atrophy Treatment include Apellis Pharmaceuticals, IVERIC bio, Alkeus Pharmaceuticals, Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Gyroscope Therapeutics, Regenerative Patch Technologies and Roche Holding AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Geographic Atrophy Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Geographic Atrophy Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Geographic Atrophy Treatment Market Segment Percentages, by Type, 2021 (%)
Late-stage (Phase III) Treatment
Phase II Treatment
Phase I Treatment
Pre-Clinical Stage Treatment
Global Geographic Atrophy Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Geographic Atrophy Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Geographic Atrophy Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Geographic Atrophy Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Geographic Atrophy Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Geographic Atrophy Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Apellis Pharmaceuticals
IVERIC bio
Alkeus Pharmaceuticals
Hemera Biosciences
Allegro Ophthalmics
Stealth BioTherapeutics
Gyroscope Therapeutics
Regenerative Patch Technologies
Roche Holding AG
Gensight Biologics SA
NGM Biopharmaceuticals
AstraZeneca
Lineage Cell Therapeutics
Allergan
